Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
  • Home
  • About Us
  • Log In

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Video
  4. /
  5. A new handle on...

A new handle on Kennedy’s disease

September 6, 2016abidemi.uruejoma@gmx.ch

A new handle on Kennedy’s disease. From the IRB Barcelona 2010 Annual Report.

News

  • Myrobalan Therapeutics Awarded a Grant from the National Multiple Scle
  • Marvel Biosciences’ MB-204 Outperforms Trofinetide in Preclinica
  • Amgen’s Uplizna Shows Sustained Efficacy in Myasthenia Gravis, Pavin
  • Clene’s CNM-Au8 Shows Significant Survival Benefit in Amyotrophic La
  • Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for t
More News

Access Programs

  • Jonsson Comprehensive Cancer Center – Progressive Metastatic Cas
  • Massachusetts General Hospital – Healthy Naturally Cycling Women
  • Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal
  • Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell L
  • Kite, A Gilead Company – Relapsed/Refractory Transformed Follicu
More Access Programs
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo